| __timestamp | Alkermes plc | Alpine Immune Sciences, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 7753000 | 12199547 |
| Thursday, January 1, 2015 | 4019000 | 16054000 |
| Friday, January 1, 2016 | 2301000 | 23316000 |
| Sunday, January 1, 2017 | 7232000 | 10626000 |
| Monday, January 1, 2018 | 68895000 | 28970000 |
| Tuesday, January 1, 2019 | 52816000 | 35847000 |
| Wednesday, January 1, 2020 | 1946000 | 27185000 |
| Friday, January 1, 2021 | 1020000 | 58742000 |
| Saturday, January 1, 2022 | 393842000 | 70243000 |
| Sunday, January 1, 2023 | 270806000 | 80904000 |
| Monday, January 1, 2024 | 245326000 |
Infusing magic into the data realm
In the ever-evolving landscape of biotechnology, innovation is the lifeblood of progress. Over the past decade, Alkermes plc and Alpine Immune Sciences, Inc. have been at the forefront, channeling significant resources into research and development (R&D). From 2014 to 2023, Alkermes plc has consistently outpaced Alpine Immune Sciences in R&D spending, with a peak investment in 2022 that was over 450% higher than its 2014 expenditure. Meanwhile, Alpine Immune Sciences has shown a steady increase, culminating in a 2023 investment that is nearly seven times its 2014 figure. This trend underscores a robust commitment to innovation, with both companies striving to push the boundaries of medical science. As the biotech industry continues to grow, these investments highlight the critical role of R&D in driving future breakthroughs.
Research and Development Expenses Breakdown: AstraZeneca PLC vs Alpine Immune Sciences, Inc.
R&D Insights: How Takeda Pharmaceutical Company Limited and Alpine Immune Sciences, Inc. Allocate Funds
R&D Insights: How Neurocrine Biosciences, Inc. and Alpine Immune Sciences, Inc. Allocate Funds
Research and Development: Comparing Key Metrics for Viatris Inc. and Alpine Immune Sciences, Inc.
Research and Development Investment: Ascendis Pharma A/S vs Alkermes plc
R&D Spending Showdown: Halozyme Therapeutics, Inc. vs Alpine Immune Sciences, Inc.
Analyzing R&D Budgets: Madrigal Pharmaceuticals, Inc. vs Alpine Immune Sciences, Inc.
Alkermes plc vs Catalyst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Analyzing R&D Budgets: Alkermes plc vs ACADIA Pharmaceuticals Inc.
Research and Development Investment: TG Therapeutics, Inc. vs Alpine Immune Sciences, Inc.
R&D Spending Showdown: Alpine Immune Sciences, Inc. vs Ligand Pharmaceuticals Incorporated
Who Prioritizes Innovation? R&D Spending Compared for Alpine Immune Sciences, Inc. and Soleno Therapeutics, Inc.